BioAge Labs (BIOA) Assets Average (2024 - 2026)

BioAge Labs has disclosed Assets Average across 3 years of filings, most recently posting $397.3 million for Q2 2026.

• In Q2 2026, Assets Average rose 19.31% year-over-year to $397.3 million; the TTM figure through Jun 2026 stood at $397.3 million (up 19.31% YoY), while the FY2025 annual figure was $326.6 million, up 70.01% from the prior year.
• Assets Average came in at $397.3 million for Q2 2026 at BioAge Labs, up from $346.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $397.3 million in Q2 2026 to a low of $300.0 million in Q4 2025.
• Average Assets Average over 3 years is $341.3 million, with a median of $346.3 million recorded in 2026.
• Year-over-year, Assets Average decreased 13.75% in 2025 and climbed 19.31% in 2026.
• Over 3 years, Assets Average stood at $347.8 million in 2024, then decreased by 13.75% to $300.0 million in 2025, then jumped by 32.44% to $397.3 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $397.3 million in Q2 2026, $346.3 million in Q1 2026, and $300.0 million in Q4 2025.